期刊文献+

福州地区咽喉反流疾病患病率和相关危险因素分析 被引量:5

Analysis the risk factors and the prevalence of Laryngopharyngeal reflux disease in Fuzhou area
下载PDF
导出
摘要 目的分析福州地区咽喉反流疾病(1aryngopharyngeal reflux disease,LPRD)的患病率和相关危险因素,为LPRD的防治提供理论依据。方法采用随机整群抽样法抽取福州社区居民进行问卷调查。按照统一调查问卷,内容包括一般情况、Belafsky反流症状指数量表(reflux symptom index,RSI)和相关危险因素,其中RSI>13分为LPRD组,≤13分为非LPRD组,调查资料进行统计分析。结果共发放问卷4100份,其中有效问卷4063例,LPRD患病率为5.00%(203/4063)。经常进食过饱、常饮浓茶、绝经、经常鼻塞流涕、经常扁桃体炎是LPRD发生的危险因素。结论福州地区人群LPRD与多种因素密切相关。 OBJECTIVE To assess the prevalence and analyze the influence factors of laryngopharyngeal reflux disease(LPRD) in the Fuzhou region, in order to provide a theoretical basis for the development of prevention and control measures for LPRD. METHODS A questionnaire survey in residents in Fuzhou by a random cluster sampling was carried out. Individual information, reflux symptom index(RSI) of Belafsky and risk factors were included. Patients more than 13 scores of RSI were defined as LPRD. Data were statistically analyzed. RESULTS A total of 4100 residents were investigated, 4063 of them were available. The prevalence of LPRD was 5.00%. Often eating too much, often drinking strong tea, menolipsis, rhinitis, tonsillitis were closely related to LPRD, CONCLUSION The prevalence of LPRD in Fuzhou region were closely related to many factors.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2017年第4期202-206,共5页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 患病率 危险因素 咽喉反流疾病 症状指数量 福州 Prevalence Risk Factors laryngopharyngeal reflux disease symptom index scale Fuzhou
  • 相关文献

参考文献4

二级参考文献38

  • 1黄益灯,周水淼,郑宏良,李兆基,温武,张速勤,耿利萍.成人杓状软骨切除术前后声门测量及嗓音分析[J].中华耳鼻咽喉科杂志,2004,39(9):554-557. 被引量:14
  • 2侯丽珍,韩德民,徐文,张丽,叶京英,王军.儿童声嘶及良性增生性声带疾病的嗓音频谱分析[J].中国耳鼻咽喉头颈外科,2005,12(12):771-774. 被引量:11
  • 3黄益灯,郑宏良,周水淼,陈建福,李兆基,夏斯文,黄子喜,罗春娟.双侧声带麻痹不同术式治疗前后声门测量及嗓音评价[J].中华耳鼻咽喉头颈外科杂志,2006,41(9):648-652. 被引量:9
  • 4陈世彩,郑宏良,周水淼,李兆基,陈刚,张贤,荆建军,陈东辉,施剑斌.杓状软骨内移联合喉返神经修复术治疗单侧声带麻痹[J].中国耳鼻咽喉头颈外科,2007,14(4):223-226. 被引量:13
  • 5Hudson LD, Garbern JY, Kamholz JA. Pelizaeus-Merzbacher disease//Lazzarini RA, ed. Myelin biology and disorders, Vol. 2. San Diego, CA: Elsevier Academic Press, 2004: 867-885.
  • 6Woodward K, Malcolm S. CNS myelination and PLP1 gene dosage. Pharmacogenomics, 2001,2:263-272.
  • 7Wolf NI, Sistermans EA, Cundall M, et al. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain, 2005, 128:743-751.
  • 8Gao Q, Thurston VC, Vance GH, et al. Genetic diagnosis of PLP gene duplications/deletions in patients with Pelizaeus-Merzbacher disease. Clin Genet, 2005, 68:466-467.
  • 9Ken Inoue. PLPl-related inherited dysmyelinating disorder: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics, 2005, 6: 1-16.
  • 10Regis S, Grossi S, Lualdi S, et al. Diagnosis of Pelizaeus-Merzbacher disease: detection of proteolipid protein gene copy number by real-time PCR. Neurogenetics, 2005, 6:73-78.

共引文献15

同被引文献47

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部